138 related articles for article (PubMed ID: 11012149)
21. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
22. Changes in the cytokine regulation of stem cell self-renewal during ontogeny.
Eaves C; Zandstra P; Conneally E; Miller C; Cashman J; Petzer A; Piret J
Stem Cells; 1998; 16 Suppl 1():177-84. PubMed ID: 11012160
[TBL] [Abstract][Full Text] [Related]
23. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
Chávez-González A; Ayala-Sánchez M; Sánchez-Valle E; Ruiz-Sánchez E; Arana-Trejo RM; Vela-Ojeda J; Mayani H
Leuk Res; 2006 Mar; 30(3):286-95. PubMed ID: 16111748
[TBL] [Abstract][Full Text] [Related]
24. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
[TBL] [Abstract][Full Text] [Related]
25. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
26. The chronic myeloid leukemia stem cell.
Nicholson E; Holyoake T
Clin Lymphoma Myeloma; 2009; 9 Suppl 4():S376-81. PubMed ID: 20007106
[TBL] [Abstract][Full Text] [Related]
27. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
[TBL] [Abstract][Full Text] [Related]
29. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
[TBL] [Abstract][Full Text] [Related]
30. Assay systems for hematopoietic stem and progenitor cells.
Bock TA
Stem Cells; 1997; 15 Suppl 1():185-95. PubMed ID: 9368340
[TBL] [Abstract][Full Text] [Related]
31. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
Dowding CR; Gordon MY; Goldman JM
Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
[TBL] [Abstract][Full Text] [Related]
32. Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell.
McGlave P; Verfaillie C; Miller J
Stem Cells; 1993 Oct; 11 Suppl 3():10-3. PubMed ID: 7905318
[TBL] [Abstract][Full Text] [Related]
33. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
34. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
[TBL] [Abstract][Full Text] [Related]
35. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice.
Cashman J; Clark-Lewis I; Eaves A; Eaves C
Blood; 2002 Feb; 99(3):792-9. PubMed ID: 11806978
[TBL] [Abstract][Full Text] [Related]
36. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture.
Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J
Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML).
Eaves AC; Eaves CJ
Exp Hematol; 1979; 7 Suppl 5():65-75. PubMed ID: 299448
[TBL] [Abstract][Full Text] [Related]
38. Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
Haematologica; 2000 Nov; 85(11 Suppl):18-25. PubMed ID: 11268318
[TBL] [Abstract][Full Text] [Related]
39. The biology of normal and neoplastic stem cells in CML.
Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
[TBL] [Abstract][Full Text] [Related]
40. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML).
Podestà M; Piaggio G; Frassoni F; Sessarego M; Benvenuto F; Figari O; Pitto A; Vassallo F; Soracco M; Pollicardo N
Bone Marrow Transplant; 1995 Oct; 16(4):549-55. PubMed ID: 8528171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
